Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

GENTEAL TEARS 0.1%-0.3% DROP

dextran 70, hypromellose 2910
$0.2979per EA
OTC

Strength

1; 3 mg/mL; mg/mL

Manufacturer

Alcon Laboratories, Inc.

NDC

00065806301

Classification

Brand

Dosage Form

SOLUTION/ DROPS

Route

OPHTHALMIC

Last Updated

4/22/2026

Active Ingredients

DEXTRAN 70; HYPROMELLOSE 2910 (4000 MPA.S)

Approval Type

OTC MONOGRAPH DRUG

FDA Application

M018

On Market Since

7/3/2018

Pharmacological Classes

Increased Intravascular Volume
Osmotic Activity
Plasma Volume Expander

Price History

1W

0.0%

1M

+0.0%

3M

-0.2%

6M

-0.2%

1Y

-0.0%

3Y

+2.3%

5Y

+14.9%

All

+10.7%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

GOLYTELY SOLUTION
Brand
52268010001•Braintree Laboratories, Inc.
$0.0060
per ML
FLEET PEDIA-LAX ENEMA
Brand
00132020220•C.B. Fleet Company, Inc.
$0.0204
per ML
MIRALAX POWDER
Brand
11523723404•Bayer HealthCare LLC
$0.0330
per GM
MIRALAX POWDER
Brand
11523723403•Bayer HealthCare LLC
$0.0370
per GM
MIRALAX POWDER
Brand
11523723402•Bayer HealthCare LLC
$0.0427
per GM
KLOR-CON 10 MEQ TABLET
Brand
00245531601•Upsher-Smith Laboratories LLC
$0.1093
per EA
KLOR-CON 10 MEQ TABLET
Brand
00245531611•Upsher-Smith Laboratories LLC
$0.1093
per EA
KLOR-CON 10 MEQ TABLET
Brand
00245531615•Upsher-Smith Laboratories LLC
$0.1093
per EA
KLOR-CON 8 MEQ TABLET
Brand
00245531501•Upsher-Smith Laboratories LLC
$0.1232
per EA
KLOR-CON 8 MEQ TABLET
Brand
00245531511•Upsher-Smith Laboratories LLC
$0.1232
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy